Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Real-World Study of Pathology Artificial Intelligence for Predicting Molecular Alterations in Gliomas

NCT07263711 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT07263711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07263711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Real-World Study of Pathology Artificial Intelligence for Predicting Molecular Alterations in Gliomas
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2025
Completion date
September 1, 2030
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma